BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36029220)

  • 1. Comprehensive characterization of genomic and radiologic features reveals distinct driver patterns of RTK/RAS pathway in ground-glass opacity pulmonary nodules.
    Yu F; Peng M; Bai J; Zhu X; Zhang B; Tang J; Liu W; Chen C; Wang X; Chen M; Tan S; Sun Y; Liang Q; Li J; Hu Y; Liao A; Hu H; He Y; Xiao X; Wang B; Xing G; Xu Y; Chen R; Xia X; Chen X
    Int J Cancer; 2022 Dec; 151(11):2020-2030. PubMed ID: 36029220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth.
    Kobayashi Y; Mitsudomi T; Sakao Y; Yatabe Y
    Ann Oncol; 2015 Jan; 26(1):156-161. PubMed ID: 25361983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread.
    Chung JH; Choe G; Jheon S; Sung SW; Kim TJ; Lee KW; Lee JH; Lee CT
    J Thorac Oncol; 2009 Dec; 4(12):1490-5. PubMed ID: 19844187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
    Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G
    Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are there imaging characteristics associated with epidermal growth factor receptor and KRAS mutations in patients with adenocarcinoma of the lung with bronchioloalveolar features?
    Glynn C; Zakowski MF; Ginsberg MS
    J Thorac Oncol; 2010 Mar; 5(3):344-8. PubMed ID: 20087229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiomics Analysis Reveals Distinct Immunogenomic Features of Lung Cancer with Ground-Glass Opacity.
    Chen K; Bai J; Reuben A; Zhao H; Kang G; Zhang C; Qi Q; Xu Y; Hubert S; Chang L; Guan Y; Feng L; Zhang K; Zhang K; Yi X; Xia X; Cheng S; Yang F; Zhang J; Wang J
    Am J Respir Crit Care Med; 2021 Nov; 204(10):1180-1192. PubMed ID: 34473939
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation exploration among CT imaging, pathology and genotype of pulmonary ground-glass opacity.
    Cai Y; Chen T; Zhang S; Tan M; Wang J
    J Cell Mol Med; 2023 Jul; 27(14):2021-2031. PubMed ID: 37340599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, pathological and thin-section CT features of persistent multiple ground-glass opacity nodules: comparison with solitary ground-glass opacity nodule.
    Kim TJ; Goo JM; Lee KW; Park CM; Lee HJ
    Lung Cancer; 2009 May; 64(2):171-8. PubMed ID: 18799230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Discrepancy of Driver Mutations in Patients with NSCLC and Synchronous Multiple Lung Ground-Glass Nodules.
    Wu C; Zhao C; Yang Y; He Y; Hou L; Li X; Gao G; Shi J; Ren S; Chu H; Zhou C; Zhang J; Schmid-Bindert G
    J Thorac Oncol; 2015 May; 10(5):778-783. PubMed ID: 25629635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules.
    Cho JH; Choi YS; Kim J; Kim HK; Zo JI; Shim YM
    Ann Thorac Surg; 2015 Jan; 99(1):218-22. PubMed ID: 25440277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience.
    Yamaguchi M; Furuya A; Edagawa M; Taguchi K; Shimamatsu S; Toyokawa G; Toyozawa R; Nosaki K; Hirai F; Seto T; Takenoyama M; Ichinose Y
    Surg Oncol; 2015 Sep; 24(3):258-63. PubMed ID: 26298200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct cellular immune profiles in lung adenocarcinoma manifesting as pure ground glass opacity versus solid nodules.
    Qu R; Ye F; Hu S; Wang B; Qin S; Xiong J; Fu X; Li L; Cai Y
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3775-3788. PubMed ID: 35986758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNF213 gene mutation in circulating tumor DNA detected by targeted next-generation sequencing in the assisted discrimination of early-stage lung cancer from pulmonary nodules.
    Jiang N; Zhou J; Zhang W; Li P; Liu Y; Shi H; Zhang C; Wang Y; Zhou C; Peng C; Zhang W; Hao Y; Sun Q; Li Y; Zhao X
    Thorac Cancer; 2021 Jan; 12(2):181-193. PubMed ID: 33200540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent oncogene mutation profile in Chinese patients with stage Ib lung adenocarcinoma.
    Wen YS; Cai L; Zhang XW; Zhu JF; Zhang ZC; Shao JY; Zhang LJ
    Medicine (Baltimore); 2014 Dec; 93(29):e296. PubMed ID: 25546673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan.
    Chang B; Hwang JH; Choi YH; Chung MP; Kim H; Kwon OJ; Lee HY; Lee KS; Shim YM; Han J; Um SW
    Chest; 2013 Jan; 143(1):172-178. PubMed ID: 22797081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant pure pulmonary ground-glass opacity nodules: prognostic implications.
    Park JH; Lee KS; Kim JH; Shim YM; Kim J; Choi YS; Yi CA
    Korean J Radiol; 2009; 10(1):12-20. PubMed ID: 19182498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ground-Glass Opacity Lung Nodules in the Era of Lung Cancer CT Screening: Radiology, Pathology, and Clinical Management.
    Pedersen JH; Saghir Z; Wille MM; Thomsen LH; Skov BG; Ashraf H
    Oncology (Williston Park); 2016 Mar; 30(3):266-74. PubMed ID: 26984222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular markers and changes of computed tomography appearance in lung adenocarcinoma with ground-glass opacity.
    Yoshida Y; Kokubu A; Suzuki K; Kuribayashi H; Tsuta K; Matsuno Y; Kusumoto M; Kanai Y; Asamura H; Hirohashi S; Shibata T
    Jpn J Clin Oncol; 2007 Dec; 37(12):907-12. PubMed ID: 18089646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasiveness and surgical timing evaluation by clinical features of ground-glass opacity nodules in lung cancers.
    Chen PH; Chang KM; Tseng WC; Chen CH; Chao JI
    Thorac Cancer; 2019 Nov; 10(11):2133-2141. PubMed ID: 31571421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of multiple pure ground-glass opacity lesions in patients with bronchioloalveolar carcinoma.
    Kim HK; Choi YS; Kim J; Shim YM; Lee KS; Kim K
    J Thorac Oncol; 2010 Feb; 5(2):206-10. PubMed ID: 19901852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.